These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 32875744)
1. Molecular analysis of 76 Chinese hemophilia B pedigrees and the identification of 10 novel mutations. Huang L; Li L; Lin S; Chen J; Li K; Fan D; Jin W; Li Y; Yang X; Xiong Y; Li F; Yang X; Li M; Li Q Mol Genet Genomic Med; 2020 Nov; 8(11):e1482. PubMed ID: 32875744 [TBL] [Abstract][Full Text] [Related]
2. The characteristics and spectrum of F9 mutations in Chinese sporadic haemophilia B pedigrees. Lu Y; Wu X; Dai J; Ding Q; Wu W; Wang X Haemophilia; 2019 Mar; 25(2):316-323. PubMed ID: 30648777 [TBL] [Abstract][Full Text] [Related]
3. Assessment of the F9 genotype-specific FIX inhibitor risks and characterisation of 10 novel severe F9 defects in the first molecular series of Argentinian patients with haemophilia B. Radic CP; Rossetti LC; Abelleyro MM; Candela M; Pérez Bianco R; de Tezanos Pinto M; Larripa IB; Goodeve A; De Brasi C Thromb Haemost; 2013 Jan; 109(1):24-33. PubMed ID: 23093250 [TBL] [Abstract][Full Text] [Related]
4. Identification of mutations in the F8 and F9 gene in families with haemophilia using targeted high-throughput sequencing. Lyu C; Xue F; Liu X; Liu W; Fu R; Sun T; Wu R; Zhang L; Li H; Zhang D; Yang R; Zhang L Haemophilia; 2016 Sep; 22(5):e427-34. PubMed ID: 27292088 [TBL] [Abstract][Full Text] [Related]
5. Spectrum of F9 mutations in Chinese haemophilia B patients: identification of 20 novel mutations. Yu T; Dai J; Liu H; Ding Q; Lu Y; Wang H; Wang X; Fu Q Pathology; 2012 Jun; 44(4):342-7. PubMed ID: 22544209 [TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of phenotypes and genetics in 21 Chinese families with haemophilia B: characterization of five novel mutations. Guo ZP; Yang LH; Qin XY; Liu XE; Chen JF; Zhang YF Haemophilia; 2014 Nov; 20(6):859-65. PubMed ID: 25251685 [TBL] [Abstract][Full Text] [Related]
7. Identification of mutations in the F9 gene including exon deletion by multiplex ligation-dependent probe amplification in 33 unrelated Korean patients with haemophilia B. Kwon MJ; Yoo KY; Kim HJ; Kim SH Haemophilia; 2008 Sep; 14(5):1069-75. PubMed ID: 18624698 [TBL] [Abstract][Full Text] [Related]
8. Molecular pathogenesis of a novel Met394Thr variant causing hemophilia B. Lu L; Wang L; Shen W; Fang S; Zhao L; Hu X; Yang L; Wang G Mol Genet Genomic Med; 2023 May; 11(5):e2147. PubMed ID: 36795372 [TBL] [Abstract][Full Text] [Related]
9. The spectrum of FVIII gene variants detected by next generation sequencing in 236 Chinese non-inversion hemophilia A pedigrees. Chen J; Li Q; Lin S; Li F; Huang L; Jin W; Yang X; Li Y; Li K; Xiong Y; Fan D; Zheng L; Luo D; Li L; Yang X Thromb Res; 2021 Jun; 202():8-13. PubMed ID: 33706050 [TBL] [Abstract][Full Text] [Related]
10. Mutation Spectrum and Genotype-Phenotype Analyses in a Pakistani Cohort With Hemophilia B. Khan MTM; Naz A; Ahmed J; Shamsi T; Ahmed S; Ahmed N; Imran A; Farooq N; Khan MTH; Taj AS Clin Appl Thromb Hemost; 2018 Jul; 24(5):741-748. PubMed ID: 28752769 [TBL] [Abstract][Full Text] [Related]
11. The Canadian "National Program for hemophilia mutation testing" database: a ten-year review. Rydz N; Leggo J; Tinlin S; James P; Lillicrap D Am J Hematol; 2013 Dec; 88(12):1030-4. PubMed ID: 23913812 [TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of hemophilia B patients in Colombia. Parrado Jara YA; Yunis Hazbun LK; Linares A; Yunis Londoño JJ Mol Genet Genomic Med; 2020 May; 8(5):e1210. PubMed ID: 32155688 [TBL] [Abstract][Full Text] [Related]
13. Efficient detection of factor IX mutations by denaturing high-performance liquid chromatography in Taiwanese hemophilia B patients, and the identification of two novel mutations. Lin PC; Su YN; Liao YM; Chang TT; Tsai SP; Shu HL; Chiou SS Kaohsiung J Med Sci; 2014 Apr; 30(4):187-93. PubMed ID: 24656159 [TBL] [Abstract][Full Text] [Related]
14. Advanced cell-based modeling of the royal disease: characterization of the mutated F9 mRNA. Martorell L; Luce E; Vazquez JL; Richaud-Patin Y; Jimenez-Delgado S; Corrales I; Borras N; Casacuberta-Serra S; Weber A; Parra R; Altisent C; Follenzi A; Dubart-Kupperschmitt A; Raya A; Vidal F; Barquinero J J Thromb Haemost; 2017 Nov; 15(11):2188-2197. PubMed ID: 28834196 [TBL] [Abstract][Full Text] [Related]
15. A genetic analysis of 23 Chinese patients with hemophilia B. Wang QY; Hu B; Liu H; Tang L; Zeng W; Wu YY; Cheng ZP; Hu Y Sci Rep; 2016 Apr; 6():25024. PubMed ID: 27109384 [TBL] [Abstract][Full Text] [Related]
16. [Carrier diagnosis of F9 gross deletion by multiple ligation-dependent probe amplification in hemophilia B]. Chen X; Liang Y; Yan M; Liu JZ Zhonghua Xue Ye Xue Za Zhi; 2012 Dec; 33(12):1038-41. PubMed ID: 23363799 [TBL] [Abstract][Full Text] [Related]
17. F9 mRNA splicing aberration due to a deep Intronic structural variation in a patient with moderate hemophilia B. Odaira K; Kawashima F; Tamura S; Suzuki N; Tokoro M; Hayakawa Y; Suzuki A; Kanematsu T; Okamoto S; Takagi A; Katsumi A; Matsushita T; Shima M; Nogami K; Kojima T; Hayakawa F Thromb Res; 2022 May; 213():91-96. PubMed ID: 35313235 [TBL] [Abstract][Full Text] [Related]
18. Normal activated partial thromboplastin time in Chinese patients with mild hemophilia B. Wang X; Tang N; Shen N; Zhu Y; Lu Y; Gao L Hematology; 2020 Dec; 25(1):484-488. PubMed ID: 33295842 [TBL] [Abstract][Full Text] [Related]
19. Risk factors associated with inhibitor development in Chinese patients with haemophilia B. Zhou J; Ding Q; Chen Z; Yang H; Lin L; Wang H; Wang X; Wu R Haemophilia; 2015 Jul; 21(4):e286-93. PubMed ID: 25929987 [TBL] [Abstract][Full Text] [Related]
20. Mutation analysis of a cohort of US patients with hemophilia B. Li T; Miller CH; Driggers J; Payne AB; Ellingsen D; Hooper WC Am J Hematol; 2014 Apr; 89(4):375-9. PubMed ID: 24375831 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]